J. Chua

发表

Effectiveness of 8 Weeks of Ledipasvir/Sofosbuvir for Hepatitis C in HCV–HIV-Coinfected Patients

E. Heil, K. Claeys, L. Hynicka, 2019, Antiviral therapy.

Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression

S. Kottilil, A. Khanam, J. Chua, 2021, International journal of molecular sciences.

Are we nearing the end in the fight against hepatitis C?

S. Kottilil, J. Chua, 2017, Expert review of gastroenterology & hepatology.

Evolution of Nipah Virus Infection: Past, Present, and Future Considerations

S. Kottilil, S. Narayanan, N. Hauser, 2021, Tropical medicine and infectious disease.

Herpes zoster vaccine for the elderly: boosting immunity.

Wilbur H. Chen, J. Chua, Joel V. Chua, 2010, Aging health.

ReviewPandemic potential of Nipah virus infection: Winging it?Naomi Hauser 1

S. Narayanan, N. Hauser, J. Chua, 2021 .

Increased Risk of Severe COVID-19 Disease in Pregnancy in a Multicenter Propensity Score-Matched Study.

H. Seung, O. Turan, S. Narayanan, 2021, medRxiv.

COVID-19: Pitfalls in Offering Research Participation as Therapy in Clinical Settings

S. Narayanan, E. Heil, J. Chua, 2020, Journal of General Internal Medicine.

Sofosbuvir and velpatasvir: a stellar option for patients with decompensated hepatitis C virus (HCV) cirrhosis.

S. Kottilil, J. Chua, Joel V. Chua, 2016, Annals of translational medicine.

COVID-19 Vaccines—All You Want to Know

S. Narayanan, J. Chua, Akira A. Shishido, 2023, Seminars in Respiratory and Critical Care Medicine.

COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease

J. Baddley, S. Narayanan, J. Chua, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Current Trends and Limitations in Dengue Antiviral Research

Daniel J. Deredge, J. Chua, J. Obi, 2021, Tropical medicine and infectious disease.

Neglected but not Forgotten: Current Trends and Limitations in Dengue Antiviral Research

Daniel J. Deredge, J. Chua, J. Obi, 2021 .

Humanized Mice in Dengue Research: A Comparison with Other Mouse Models

J. Castellanos, M. Velandia-Romero, S. Medina-Moreno, 2020, Vaccines.

Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study

Yang Liu, S. Koletar, J. Lake, 2022, The Lancet Infectious Diseases.

Dengue Infections in Colombia: Epidemiological Trends of a Hyperendemic Country

S. Medina-Moreno, J. Zapata, J. Chua, 2020, Tropical medicine and infectious disease.

Short‐duration treatment with the novel non‐nucleoside inhibitor CDI‐31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open‐label study

A. Ntem-Mensah, B. Poonia, Sam S Lee, 2020, Journal of medical virology.

Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial

D. Montefiori, R. Gottardo, G. Ferrari, 2021, Vaccine.

Humanized Mice for the Study of Dengue Disease Pathogenesis: Biological Assays.

J. Bryant, S. Medina-Moreno, J. Zapata, 2021, Methods in molecular biology.

A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection

S. Kottilil, Alip Ghosh, J. Chua, 2022, Journal of medical virology.

Tick-borne infections in the United States.

George G A Pujalte, J. Chua, 2013, Primary care.

Bench-to-bedside review: Vaccine protection strategies during pandemic flu outbreaks

Wilbur H. Chen, J. Chua, Joel V. Chua, 2010, Critical care.

Bench-to-bedside review : Vaccine protection strategies during pandemic fl u outbreaks

Wilbur H. Chen, J. Chua, Joel V. Chua, 2022 .

Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial

R. Talwani, J. Baddley, S. Bentzen, 2020, Trials.

The effect of decreasing amounts of live virus, while antigen content remains constant, on immunogenicity of Oka/Merck varicella vaccine.

B. Watson, B. Kuter, S. Starr, 1993, The Journal of infectious diseases.

Immune-Mediated Pathogenesis in Dengue Virus Infection

K. Lyke, A. Khanam, J. Chua, 2022, Viruses.

A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains

F. Perdomo-Celis, S. Medina-Moreno, J. Zapata, 2023, Microorganisms.

Variability of CD4+ cell counts in HIV-1 uninfected volunteers who are eligible for a Phase I HIV vaccine study.

R. Gallo, D. Dong, B. Gilliam, 2020, Journal of acquired immune deficiency syndromes.

Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways

S. Kottilil, Alip Ghosh, A. Khanam, 2023, Journal of Translational Medicine.

Campylobacter fetus aortitis in a patient with HIV

J. Chua, Uzoamaka A Eke, James B. Doub, 2021, IDCases.

Assessment of coronary inflammation in antiretroviral treated people with HIV infection and active HIV/hepatitis C virus co-infection

Pratik A. Patel, R. Weiss, J. Jeudy, 2021, AIDS.

A Pilot Study of Safety and Efficacy of HCV Retreatment with sofosbuvir/velpatasvir/voxilaprevir in Patients With or Without HIV (RESOLVE STUDY).

H. Masur, S. Kottilil, P. Mathur, 2019, Journal of hepatology.

Increased risk of severe COVID-19 in pregnancy in a multicenter propensity score-matched study

H. Seung, O. Turan, S. Turan, 2023, Journal of perinatal medicine.